Artificial intelligence for COVID-19: battling the pandemic with computational intelligence
Open Access
- 21 October 2021
- journal article
- review article
- Published by Elsevier in Intelligent Medicine
- Vol. 2 (1) , 13-29
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation (1750326, 2027970)
- National Institutes of Health (R01MH124740, RF1AG072449)
- Bill and Melinda Gates Foundation (CORONAVIRUSHUB-D-21-00125)
This publication has 134 references indexed in Scilit:
- Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic DataMolecular Pharmaceutics, 2016
- DeepTox: Toxicity Prediction using Deep LearningFrontiers in Environmental Science, 2016
- Deep Neural Nets as a Method for Quantitative Structure–Activity RelationshipsJournal of Chemical Information and Modeling, 2015
- Quantifying the chemical beauty of drugsNature Chemistry, 2012
- Differentially Private Empirical Risk Minimization2011
- Network medicine: a network-based approach to human diseaseNature Reviews Genetics, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- The Mathematics of Infectious DiseasesSIAM Review, 2000
- Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care unitsCritical Care Medicine, 1998